Doctor profile · Federal record
Dr. Aung Bajaj, M.D
Hematology & Oncology Physician (CMS: Internal Medicine) · Tucson, AZ
- NPI 1598177255
- Accepts Medicare
- MIPS 95.7 / 100 · 2023
- 12 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
603 N Wilmot RD Ste 151
Tucson, AZ 857112701
(520) 420-2560
fax (520) 420-2562 - Mailing address
-
5301 E Grant RD, Attn: Medical Staff
Tucson, AZ 85712
Credentials & registration
- NPI registered
- May 2014 — 12 yrs on file
- Profile last updated
- May 12, 2025
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #53908
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1598177255. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
44,899
Distinct HCPCS
10
Medicare allowed
$1,230,218
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 12,780 | 21 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,465 | 19 | $49 | |
J0185 |
Injection, aprepitant, 1 mg | 6,500 | 35 | $2 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,220 | 12 | $46 | |
J0897 |
Injection, denosumab, 1 mg | 2,400 | 20 | $23 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,400 | 14 | $42 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 1,288 | 12 | $21 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,272 | 64 | $0 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,250 | 44 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 620 | 45 | $1 |
In context: peer comparison
Among 21 peers in Tucson Hematology & Oncology Physician, average services per provider: 951. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$4,390
Transactions
111
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Taiho Oncology, INC. | 3 | $1,435.08 | |
| Celgene Corporation | 19 | $269.20 | |
| Novartis Pharmaceuticals Corporation | 17 | $267.98 | |
| Pfizer INC. | 13 | $215.77 | |
| Janssen Biotech, INC. | 7 | $198.71 | |
| Sumitomo Pharma America, INC. | 8 | $177.09 | |
| AstraZeneca Pharmaceuticals Lp | 8 | $172.04 | |
| Abbvie INC. | 7 | $146.95 | |
| Gilead Sciences, INC. | 6 | $138.82 | |
| Eisai INC. | 6 | $115.85 | |
| Genmab U.S., INC. | 4 | $112.00 | |
| Aveo Pharmaceuticals, INC. | 1 | $84.50 | |
| Bayer Healthcare Pharmaceuticals INC. | 5 | $78.31 | |
| Array Biopharma INC | 4 | $77.95 | |
| Blueprint Medicines Corporation | 3 | $67.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
780
Patients
262
Total drug cost
$2,554,253
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 110 | 31 | $1,719 |
| Prednisone | Generic | 87 | 43 | $632 |
| Ondansetron Hcl | Generic | 77 | 46 | $1,596 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 57 | 0 | $1,006,761 |
| Prochlorperazine Maleate | Generic | 51 | 32 | $1,082 |
| Hydroxyurea | Generic | 48 | 13 | $3,120 |
| Abiraterone Acetate | Generic | 46 | 0 | $131,308 |
| Pomalyst (Pomalidomide) | Brand | 44 | 0 | $974,032 |
| Eliquis (Apixaban) | Brand | 42 | 14 | $40,440 |
| Dexamethasone | Generic | 41 | 22 | $1,585 |
Frequently asked questions
What is Dr. Aung Bajaj's medical specialty?
Dr. Aung Bajaj practices Hematology & Oncology Physician in Tucson, AZ.
Where does Dr. Aung Bajaj practice?
Dr. Aung Bajaj practices at 603 N Wilmot RD Ste 151, Tucson, AZ 857112701. Office phone: 5204202560.
What is Dr. Aung Bajaj's NPI?
Dr. Aung Bajaj's National Provider Identifier (NPI) is 1598177255, issued by NPPES.
Does Dr. Aung Bajaj accept Medicare assignment?
Yes. Dr. Aung Bajaj accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Aung Bajaj commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.